Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosis Feedback from hepatology community supports US market potential from ...

BEVERLY, MA--(Marketwired - December 11, 2017) - BioVie Inc. (BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced ...

When fluid accumulates in the abdominal cavity, it is called ascites. Cirrhosis of the liver is the most common cause of ascites but other conditions such as heart failure, kidney failure, infection ...

Challenges in developing drugs for pancreatic ductal adenocarcinoma (PDAC) include obtaining metastatic cancer tissue for research and validating biomarkers predicative for personalised therapeutic ...

Sterile ascites after ventriculoperitoneal shunting is rare and usually of unknown cause. 1 We describe a patient in whom an inflammatory reaction to silicone tubing used in the creation of a shunt ...

Ascites develops in cirrhosis from increased portal pressure within the liver, with transudation of fluid and proteins into the pace of Disse. When fluid accumulation exceeds the capacity of the ...

ASCITES is a problem frequently encountered and often unsatisfactorily treated. An adjunct in the therapy of ascites has been tried in a limited number of cases and has seemed sufficiently helpful to ...

The patient initially presented with massive splenomegaly and hypersplenism. About 2 years later, she developed ascites. At this time, the SERUM-ASCITES ALBUMIN GRADIENT was 1.9 g/dl, with a total ...

1. Who is the specialist I should consult when I notice ascites? Ascites is treated by a gastroenterologist who will examine the patient first, and may then redirect the patient to another specialist ...

A previously healthy 21-year-old man presented to the emergency department with a 3-month history of lethargy and progressive abdominal pain and distention. He reported 6–8 watery, nonbloody bowel ...

Marketresearch.biz reports that the Ascites Market size is expected to be worth around USD 4.1 Bn by 2032 from USD 2.2 Bn in 2022, growing at a CAGR of 6.5% during the forecast period from 2023 to ...